Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Elife ; 122024 May 10.
Article in English | MEDLINE | ID: mdl-38727712

ABSTRACT

Vesicles within presynaptic terminals are thought to be segregated into a variety of readily releasable and reserve pools. The nature of the pools and trafficking between them is not well understood, but pools that are slow to mobilize when synapses are active are often assumed to feed pools that are mobilized more quickly, in a series. However, electrophysiological studies of synaptic transmission have suggested instead a parallel organization where vesicles within slowly and quickly mobilized reserve pools would separately feed independent reluctant- and fast-releasing subdivisions of the readily releasable pool. Here, we use FM-dyes to confirm the existence of multiple reserve pools at hippocampal synapses and a parallel organization that prevents intermixing between the pools, even when stimulation is intense enough to drive exocytosis at the maximum rate. The experiments additionally demonstrate extensive heterogeneity among synapses in the relative sizes of the slowly and quickly mobilized reserve pools, which suggests equivalent heterogeneity in the numbers of reluctant and fast-releasing readily releasable vesicles that may be relevant for understanding information processing and storage.


Subject(s)
Hippocampus , Synapses , Synaptic Vesicles , Animals , Hippocampus/physiology , Synaptic Vesicles/metabolism , Synaptic Vesicles/physiology , Synapses/physiology , Synaptic Transmission/physiology , Rats , Exocytosis , Presynaptic Terminals/physiology
2.
Elife ; 102021 11 17.
Article in English | MEDLINE | ID: mdl-34787081

ABSTRACT

De novo protein synthesis is required for synapse modifications underlying stable memory encoding. Yet neurons are highly compartmentalized cells and how protein synthesis can be regulated at the synapse level is unknown. Here, we characterize neuronal signaling complexes formed by the postsynaptic scaffold GIT1, the mechanistic target of rapamycin (mTOR) kinase, and Raptor that couple synaptic stimuli to mTOR-dependent protein synthesis; and identify NMDA receptors containing GluN3A subunits as key negative regulators of GIT1 binding to mTOR. Disruption of GIT1/mTOR complexes by enhancing GluN3A expression or silencing GIT1 inhibits synaptic mTOR activation and restricts the mTOR-dependent translation of specific activity-regulated mRNAs. Conversely, GluN3A removal enables complex formation, potentiates mTOR-dependent protein synthesis, and facilitates the consolidation of associative and spatial memories in mice. The memory enhancement becomes evident with light or spaced training, can be achieved by selectively deleting GluN3A from excitatory neurons during adulthood, and does not compromise other aspects of cognition such as memory flexibility or extinction. Our findings provide mechanistic insight into synaptic translational control and reveal a potentially selective target for cognitive enhancement.


Subject(s)
Memory/physiology , Protein Biosynthesis/physiology , Receptors, N-Methyl-D-Aspartate/metabolism , TOR Serine-Threonine Kinases/metabolism , Animals , Female , Male , Mechanistic Target of Rapamycin Complex 1 , Mice, Inbred C57BL , Mice, Transgenic , Signal Transduction
4.
Article in English | MEDLINE | ID: mdl-31824292

ABSTRACT

The connection strength of most chemical synapses changes dynamically during normal use as a function of the recent history of activity. The phenomenon is known as short-term synaptic plasticity or synaptic dynamics, and is thought to be involved in processing and filtering information as it is transmitted across the synaptic cleft. Multiple presynaptic mechanisms have been implicated, but large gaps remain in our understanding of how the mechanisms are modulated and how they interact. One important factor is the timing of recruitment of synaptic vesicles to a readily-releasable pool. A number of studies have concluded that activity and/or residual Ca2+ can accelerate the mechanism, but alternative explanations for some of the evidence have emerged. Here I review the methodology that we have developed for isolating the recruitment and the dependence on activity from other kinds of mechanisms that are activated concurrently.

5.
Brain Struct Funct ; 224(9): 3263-3276, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31667576

ABSTRACT

Most vesicles in the interior of synaptic terminals are clustered in clouds close to active zone regions of the plasma membrane where exocytosis occurs. Electron-dense structures, termed bridges, have been reported between a small minority of pairs of neighboring vesicles within the clouds. Synapsin proteins have been implicated previously, but the existence of the bridges as stable structures in vivo has been questioned. Here we use electron tomography to show that the bridges are present but less frequent in synapsin knockouts compared to wildtype. An analysis of distances between neighbors in wildtype tomograms indicated that the bridges are strong enough to resist centrifugal forces likely induced by fixation with aldehydes. The results confirm that the bridges are stable structures and that synapsin proteins are involved in formation or stabilization.


Subject(s)
Presynaptic Terminals/ultrastructure , Synapsins/metabolism , Synaptic Vesicles/ultrastructure , Animals , Mice, Knockout , Models, Neurological , Presynaptic Terminals/metabolism , Synapsins/genetics , Synaptic Vesicles/metabolism
6.
Elife ; 82019 05 15.
Article in English | MEDLINE | ID: mdl-31090538

ABSTRACT

Synaptophysins 1 and 2 and synaptogyrins 1 and 3 constitute a major family of synaptic vesicle membrane proteins. Unlike other widely expressed synaptic vesicle proteins such as vSNAREs and synaptotagmins, the primary function has not been resolved. Here, we report robust elevation in the probability of release of readily releasable vesicles with both high and low release probabilities at a variety of synapse types from knockout mice missing all four family members. Neither the number of readily releasable vesicles, nor the timing of recruitment to the readily releasable pool was affected. The results suggest that family members serve as negative regulators of neurotransmission, acting directly at the level of exocytosis to dampen connection strength selectively when presynaptic action potentials fire at low frequency. The widespread expression suggests that chemical synapses may play a frequency filtering role in biological computation that is more elemental than presently envisioned. Editorial note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that all the issues have been addressed (see decision letter).


Subject(s)
Neurons/metabolism , Synaptic Vesicles/metabolism , Synaptogyrins/deficiency , Synaptophysin/deficiency , Animals , Mice, Knockout , Synaptic Transmission
7.
Nat Rev Neurosci ; 17(10): 623-35, 2016 10.
Article in English | MEDLINE | ID: mdl-27558536

ABSTRACT

GluN3-containing NMDA receptors (GluN3-NMDARs) are rarer than the 'classical' NMDARs, which are composed solely of GluN1 and GluN2 subunits, and have non-conventional biophysical, trafficking and signalling properties. In the CNS, they seem to have important roles in delaying synapse maturation until the arrival of sensory experience and in targeting non-used synapses for pruning. The reactivation of GluN3A expression at inappropriate ages may underlie maladaptive synaptic rearrangements observed in addiction, neurodegenerative diseases and other major brain disorders. Here, we discuss current evidence for these and other emerging roles for GluN3-NMDARs in the physiology and pathology of the CNS.


Subject(s)
Brain Diseases/physiopathology , Central Nervous System/physiology , Protein Subunits/physiology , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , Brain Diseases/metabolism , Central Nervous System/cytology , Central Nervous System/pathology , Humans , Models, Neurological , Receptors, N-Methyl-D-Aspartate/physiology , Signal Transduction , Synapses/metabolism , Synapses/physiology
8.
PLoS Comput Biol ; 12(4): e1004855, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27035349

ABSTRACT

The readily releasable pool (RRP) of vesicles is a core concept in studies of presynaptic function. However, operating principles lack consensus definition and the utility for quantitative analysis has been questioned. Here we confirm that RRPs at calyces of Held from 14 to 21 day old mice have a fixed capacity for storing vesicles that is not modulated by Ca2+. Discrepancies with previous studies are explained by a dynamic flow-through pool, established during heavy use, containing vesicles that are released with low probability despite being immediately releasable. Quantitative analysis ruled out a posteriori explanations for the vesicles with low release probability, such as Ca2+-channel inactivation, and established unexpected boundary conditions for remaining alternatives. Vesicles in the flow-through pool could be incompletely primed, in which case the full sequence of priming steps downstream of recruitment to the RRP would have an average unitary rate of at least 9/s during heavy use. Alternatively, vesicles with low and high release probability could be recruited to distinct types of release sites; in this case the timing of recruitment would be similar at the two types, and the downstream transition from recruited to fully primed would be much faster. In either case, further analysis showed that activity accelerates the upstream step where vesicles are initially recruited to the RRP. Overall, our results show that the RRP can be well defined in the mathematical sense, and support the concept that the defining mechanism is a stable group of autonomous release sites.


Subject(s)
Auditory Pathways/physiology , Models, Neurological , Trapezoid Body/physiology , Animals , Calcium/metabolism , Cochlear Nucleus/physiology , Computational Biology , Computer Simulation , Electric Stimulation , Excitatory Postsynaptic Potentials , Female , Male , Mice , Mice, Inbred C57BL , Neuronal Plasticity , Presynaptic Terminals/physiology , Synaptic Vesicles/physiology
9.
Neurobiol Dis ; 93: 47-56, 2016 09.
Article in English | MEDLINE | ID: mdl-27072890

ABSTRACT

Age-inappropriate expression of juvenile NMDA receptors (NMDARs) containing GluN3A subunits has been linked to synapse loss and death of spiny projection neurons of the striatum (SPNs) in Huntington's disease (HD). Here we show that suppressing GluN3A expression prevents a multivariate synaptic transmission phenotype that precedes morphological signs at early prodromal stages. We start by confirming that afferent fiber stimulation elicits larger synaptic responses mediated by both AMPA receptors and NMDARs in SPNs in the YAC128 mouse model of HD. We then show that the enhancement mediated by both is fully prevented by suppressing GluN3A expression. Strong fiber-stimulation unexpectedly elicited robust NMDAR-mediated electrogenic events (termed "upstates" or "NMDA spikes"), and the effective threshold for induction was more than 2-fold lower in YAC128 SPNs because of the enhanced synaptic transmission. The threshold could be restored to control levels by suppressing GluN3A expression or by applying the weak NMDAR blocker memantine. However, the threshold was not affected by preventing glutamate spillover from synaptic clefts. Instead, long-lasting NMDAR responses interpreted previously as activation of extrasynaptic receptors by spilled-over glutamate were caused by NMDA spikes occurring in voltage clamp mode as escape potentials. Together, the results implicate GluN3A reactivation in a broad spectrum of early-stage synaptic transmission deficits in YAC128 mice; question the current concept that NMDAR mislocalization is the pathological trigger in HD; and introduce NMDA spikes as a new candidate mechanism for coupling NMDARs to neurodegeneration.


Subject(s)
Huntington Disease/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Synaptic Transmission , Animals , Corpus Striatum/metabolism , Disease Models, Animal , Glutamic Acid/metabolism , Huntington Disease/genetics , Memantine/pharmacology , Mice , Synapses/drug effects , Synapses/metabolism , Synaptic Transmission/drug effects
10.
JAMA Neurol ; 72(4): 468-73, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25686081

ABSTRACT

Huntington disease (HD) is an inherited neurodegenerative disorder with no cure or effective palliative treatment. An ideal therapy would arrest pathogenesis at early stages before neuronal damage occurs. However, although the genetic mutation that causes HD is known, the molecular chain of events that leads from the mutation to disease is not well understood. Accumulating evidence suggests that synaptic dysregulation may be involved, and the earliest known deficit is hyperfunction of glutamate-type N-methyl-d-aspartate receptors (NMDARs) in the selectively vulnerable medium spiny neurons of the striatum. A previous study found that the mutant Htt protein interferes with downregulation of juvenile NMDAR subtypes that contain GluN3A subunits by sequestering the endocytic adaptor PACSIN1 and preventing their removal from the cell surface. Loss of PACSIN1 and consequent gain of GluN3A function reactivate a synapse pruning mechanism that is important during development but harmful when active at later stages. Suppressing the GluN3A reactivation corrected the NMDAR hyperfunction and prevented the full range of HD signs and symptoms in mouse models, encouraging efforts to develop GluN3A-selective antagonists and/or explore alternative therapeutic approaches to block GluN3A expression.


Subject(s)
Huntington Disease/metabolism , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , Disease Models, Animal , Humans , Huntington Disease/genetics , Nerve Tissue Proteins/genetics , Neurons/pathology
11.
Epilepsia ; 56(4): 535-45, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25684406

ABSTRACT

OBJECTIVE: To determine if levetiracetam (LEV) enhances the impact in excitatory presynaptic terminals of a rate-limiting mechanism in vesicle trafficking termed supply rate depression that emerges to limit synaptic transmission during heavy, epileptiform use. METHODS: The effect of LEV was measured with electrophysiologic assays of monosynaptic connections in ex vivo hippocampal slices from wild-type and synapsin knockout mice, and in primary cell culture neurons from wild-type and synaptic vesicle glycoprotein 2a (SV2a) knockout mice. RESULTS: LEV enhanced the impact of supply rate depression at Schaffer collateral synapses by shortening the time course for induction. The LEV effect was selective for supply rate depression because other presynaptic vesicle trafficking mechanisms were not affected. The half maximal effective concentration (EC50 ) was ~50 µm. The maximal effect was ~15% and occurred at 100 µm, which is a clinically relevant concentration. An experimental protocol is established for distinguishing atypical antiepileptic drugs (AEDs) that affect supply rate depression, such as LEV, from typical AEDs, such as carbamazepine, that affect upstream mechanisms. The LEV effect was abolished at synapses from knockout mice lacking SV2a and from synapses lacking synapsin 1 and 2. SIGNIFICANCE: The findings are consistent with the new hypothesis that LEV acts to treat epilepsy by accelerating the induction of supply rate depression at excitatory synapses during incipient epileptic activity. The absence of the effect in the knockouts confirms that presynaptic function is the target. More specifically, the absence in SV2a knockouts is consistent with previous binding studies suggesting that SV2a is the target for LEV. The absence in synapsin knockouts indicates that the phenotypic target intersects with the biochemical pathway that is altered in synapsin knockouts. The results from synapsin knockouts additionally suggest that development of functional analogs with increased potency might be possible because induction of supply rate depression is faster in synapsin knockouts compared to wild-type synapses treated with LEV.


Subject(s)
Long-Term Synaptic Depression/drug effects , Piracetam/analogs & derivatives , Synaptic Vesicles/drug effects , Synaptic Vesicles/metabolism , Animals , Animals, Newborn , Hippocampus/drug effects , Hippocampus/metabolism , Levetiracetam , Long-Term Synaptic Depression/physiology , Mice , Mice, Knockout , Organ Culture Techniques , Piracetam/metabolism , Piracetam/pharmacology , Protein Transport/drug effects , Protein Transport/physiology
12.
Nat Med ; 19(8): 1030-8, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23852340

ABSTRACT

Huntington's disease is caused by an expanded polyglutamine repeat in the huntingtin protein (HTT), but the pathophysiological sequence of events that trigger synaptic failure and neuronal loss are not fully understood. Alterations in N-methyl-D-aspartate (NMDA)-type glutamate receptors (NMDARs) have been implicated. Yet, it remains unclear how the HTT mutation affects NMDAR function, and direct evidence for a causative role is missing. Here we show that mutant HTT redirects an intracellular store of juvenile NMDARs containing GluN3A subunits to the surface of striatal neurons by sequestering and disrupting the subcellular localization of the endocytic adaptor PACSIN1, which is specific for GluN3A. Overexpressing GluN3A in wild-type mouse striatum mimicked the synapse loss observed in Huntington's disease mouse models, whereas genetic deletion of GluN3A prevented synapse degeneration, ameliorated motor and cognitive decline and reduced striatal atrophy and neuronal loss in the YAC128 Huntington's disease mouse model. Furthermore, GluN3A deletion corrected the abnormally enhanced NMDAR currents, which have been linked to cell death in Huntington's disease and other neurodegenerative conditions. Our findings reveal an early pathogenic role of GluN3A dysregulation in Huntington's disease and suggest that therapies targeting GluN3A or pathogenic HTT-PACSIN1 interactions might prevent or delay disease progression.


Subject(s)
Behavior, Animal , Huntington Disease/metabolism , Huntington Disease/pathology , Receptors, N-Methyl-D-Aspartate/metabolism , Synapses/metabolism , Adaptor Proteins, Signal Transducing , Animals , Carrier Proteins/metabolism , Cell Death/drug effects , Cytoskeletal Proteins , Disease Models, Animal , Gene Deletion , HEK293 Cells , Humans , Huntington Disease/physiopathology , Immunoprecipitation , Intracellular Signaling Peptides and Proteins , Mice , Motor Activity/drug effects , Mutant Proteins/chemistry , Mutant Proteins/metabolism , Mutant Proteins/toxicity , Neostriatum/metabolism , Neostriatum/pathology , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/metabolism , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Neuropeptides/metabolism , Phosphoproteins/metabolism , Protein Binding/drug effects , Protein Structure, Quaternary , Rotarod Performance Test , Synapses/drug effects , Synapses/ultrastructure
13.
J Neurosci ; 33(9): 4151-64, 2013 Feb 27.
Article in English | MEDLINE | ID: mdl-23447623

ABSTRACT

Selective control of receptor trafficking provides a mechanism for remodeling the receptor composition of excitatory synapses, and thus supports synaptic transmission, plasticity, and development. GluN3A (formerly NR3A) is a nonconventional member of the NMDA receptor (NMDAR) subunit family, which endows NMDAR channels with low calcium permeability and reduced magnesium sensitivity compared with NMDARs comprising only GluN1 and GluN2 subunits. Because of these special properties, GluN3A subunits act as a molecular brake to limit the plasticity and maturation of excitatory synapses, pointing toward GluN3A removal as a critical step in the development of neuronal circuitry. However, the molecular signals mediating GluN3A endocytic removal remain unclear. Here we define a novel endocytic motif (YWL), which is located within the cytoplasmic C-terminal tail of GluN3A and mediates its binding to the clathrin adaptor AP2. Alanine mutations within the GluN3A endocytic motif inhibited clathrin-dependent internalization and led to accumulation of GluN3A-containing NMDARs at the cell surface, whereas mimicking phosphorylation of the tyrosine residue promoted internalization and reduced cell-surface expression as shown by immunocytochemical and electrophysiological approaches in recombinant systems and rat neurons in primary culture. We further demonstrate that the tyrosine residue is phosphorylated by Src family kinases, and that Src-activation limits surface GluN3A expression in neurons. Together, our results identify a new molecular signal for GluN3A internalization that couples the functional surface expression of GluN3A-containing receptors to the phosphorylation state of GluN3A subunits, and provides a molecular framework for the regulation of NMDAR subunit composition with implications for synaptic plasticity and neurodevelopment.


Subject(s)
Endocytosis/physiology , Excitatory Postsynaptic Potentials/physiology , Neurons/metabolism , Receptors, N-Methyl-D-Aspartate/chemistry , Receptors, N-Methyl-D-Aspartate/metabolism , Tyrosine/metabolism , Adenosine Triphosphate/pharmacokinetics , Amino Acid Motifs/drug effects , Amino Acid Motifs/genetics , Analysis of Variance , Animals , Biophysics , Biotinylation , Cells, Cultured , Cerebral Cortex/cytology , Chlorocebus aethiops , Clathrin/pharmacology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Electric Stimulation , Embryo, Mammalian , Endocytosis/drug effects , Excitatory Postsynaptic Potentials/drug effects , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Glutamic Acid/pharmacology , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hippocampus/cytology , Humans , Immunoprecipitation , Mutagenesis/physiology , Mutation/physiology , Neurons/drug effects , Neurotransmitter Agents/pharmacology , Patch-Clamp Techniques , Phosphorus Isotopes/pharmacokinetics , Phosphorylation/drug effects , Pituitary Adenylate Cyclase-Activating Polypeptide/pharmacology , Protein Binding/drug effects , Protein Binding/genetics , Protein Conformation , Protein Transport/drug effects , Protein Transport/genetics , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Rats , Receptors, N-Methyl-D-Aspartate/genetics , Transfection , Transferrin/metabolism
14.
J Neurosci ; 31(32): 11563-77, 2011 Aug 10.
Article in English | MEDLINE | ID: mdl-21832187

ABSTRACT

At least two rate-limiting mechanisms in vesicle trafficking operate at mouse Schaffer collateral synapses, but their molecular/physical identities are unknown. The first mechanism determines the baseline rate at which reserve vesicles are supplied to a readily releasable pool. The second causes the supply rate to depress threefold when synaptic transmission is driven hard for extended periods. Previous models invoked depletion of a reserve vesicle pool to explain the reductions in the supply rate, but the mass-action assumption at their core is not compatible with kinetic measurements of neurotransmission under maximal-use conditions. Here we develop a new theoretical model of rate-limiting steps in vesicle trafficking that is compatible with previous and new measurements. A physical interpretation is proposed where local reserve pools consisting of four vesicles are tethered to individual release sites and are replenished stochastically in an all-or-none fashion. We then show that the supply rate depresses more rapidly in synapsin knock-outs and that the phenotype can be fully explained by changing the value of the single parameter in the model that would specify the size of the local reserve pools. Vesicle-trafficking rates between pools were not affected. Finally, optical imaging experiments argue against alternative interpretations of the theoretical model where vesicle trafficking is inhibited without reserve pool depletion. This new conceptual framework will be useful for distinguishing which of the multiple molecular and cell biological mechanisms involved in vesicle trafficking are rate limiting at different levels of synaptic throughput and are thus candidates for physiological and pharmacological modulation.


Subject(s)
Models, Neurological , Synapsins/deficiency , Synapsins/metabolism , Synaptic Vesicles/physiology , Action Potentials/genetics , Animals , Cells, Cultured , Female , Hippocampus/metabolism , Male , Mice , Mice, Knockout , Phenotype , Protein Transport/genetics , Synaptic Vesicles/genetics
15.
Neuron ; 63(3): 342-56, 2009 Aug 13.
Article in English | MEDLINE | ID: mdl-19679074

ABSTRACT

NR3A is the only NMDA receptor (NMDAR) subunit that downregulates sharply prior to the onset of sensitive periods for plasticity, yet the functional importance of this transient expression remains unknown. To investigate whether removal/replacement of juvenile NR3A-containing NMDARs is involved in experience-driven synapse maturation, we used a reversible transgenic system that prolonged NR3A expression in the forebrain. We found that removal of NR3A is required to develop strong NMDAR currents, full expression of long-term synaptic plasticity, a mature synaptic organization characterized by more synapses and larger postsynaptic densities, and the ability to form long-term memories. Deficits associated with prolonged NR3A were reversible, as late-onset suppression of transgene expression rescued both synaptic and memory impairments. Our results suggest that NR3A behaves as a molecular brake to prevent the premature strengthening and stabilization of excitatory synapses and that NR3A removal might thereby initiate critical stages of synapse maturation during early postnatal neural development.


Subject(s)
Down-Regulation/physiology , Memory/physiology , Neurons/cytology , Receptors, N-Methyl-D-Aspartate/metabolism , Synapses/physiology , Animals , Animals, Newborn , Biophysics , Disks Large Homolog 4 Protein , Electric Stimulation/methods , Food Preferences/physiology , Green Fluorescent Proteins/genetics , Guanylate Kinases , Hippocampus/cytology , Immunoprecipitation/methods , In Vitro Techniques , Intracellular Signaling Peptides and Proteins/metabolism , Maze Learning/physiology , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Electron, Transmission/methods , Neuronal Plasticity/genetics , Neuronal Plasticity/physiology , Neurons/ultrastructure , Patch-Clamp Techniques/methods , Receptors, N-Methyl-D-Aspartate/genetics , Recognition, Psychology/physiology , Silver Staining/methods , Social Behavior , Synaptic Potentials/genetics , Synaptic Potentials/physiology
16.
J Neurophysiol ; 100(2): 781-95, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18579659

ABSTRACT

This study examines the kinetics of the longest lasting form of short-term depression at excitatory hippocampal synapses. After initial depletion of the readily releasable pool (RRP), continued 20-Hz stimulation was found to be fast enough to maximally drive presynaptic neurotransmitter exocytosis; maximal is defined here as the rate needed to maintain the RRP in a nearly empty steady state. Induction of depression proceeded in two distinct phases. The first was caused by RRP depletion, whereas the second is shown to reflect the progressive reduction of the overall rate at which new vesicles are supplied to the RRP and is termed "supply-rate depression." Supply-rate depression is identified further with the emergence, during heavy use, of a rate-limiting vesicle trafficking step that slows the timing of RRP replenishment by switching from a fast (tau congruent with 7 s) to a slow (tau congruent with 1 min) vesicle supply mechanism. Both mechanisms apparently follow first-order kinetics. After the induction of the maximum amount of depression, individual synapses were able to output only <1 quantum of neurotransmitter per synapse per second, matching previous predictions based on cell biological measurements of synaptic vesicle cycling. Surprisingly, the onset of supply-rate depression occurred with a marked delay, not having a detectable impact on synaptic function until after several seconds of continuous use. The delayed onset is not consistent with traditional vesicle trafficking models, but may be important for limiting the impact of supply-rate depression to pathological episodes and might function as a native antiepilepsy device.


Subject(s)
Excitatory Postsynaptic Potentials/physiology , Hippocampus/cytology , Neural Inhibition/physiology , Neurons/physiology , Synapses/physiology , Animals , Calcium/metabolism , Cells, Cultured , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Electric Stimulation/methods , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/radiation effects , In Vitro Techniques , Kinetics , Mice , Neural Inhibition/drug effects , Neural Inhibition/radiation effects , Patch-Clamp Techniques/methods , Quinoxalines/pharmacology , Reaction Time/physiology , Reaction Time/radiation effects , Time Factors
17.
J Neurophysiol ; 99(4): 1770-86, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18199812

ABSTRACT

Short-term plasticity occurs at most central chemical synapses and includes both positive and negative components, but the principles governing interaction between components are largely unknown. The residual Ca(2+) that persists in presynaptic terminals for several seconds after repetitive use is known to enhance neurotransmitter release under artificial, low probability of release conditions where depression is absent; this is termed augmentation. However, the full impact of augmentation under standard conditions at synapses where depression dominates is not known because of possibly complicated convolution with a variety of potential depression mechanisms. This report shows that residual Ca(2+) continues to have a large enhancing impact on release at excitatory hippocampal synapses recovering from depression, including when only recently recruited vesicles are available for release. No evidence was found for gradual vesicle priming or for fast refilling of a highly releasable subdivision of the readily releasable pool (RRP). And decay of enhancement matched the clearance of residual Ca(2+), thus matching the behavior of augmentation when studied in isolation. Because of incomplete RRP replenishment, synaptic strength was not typically increased above baseline when residual Ca(2+) levels were highest. Instead residual Ca(2+) caused single pulse release probability to rebound quickly from depression and then depress quickly during subsequent bursts of activity. Together, these observations can help resolve discrepancies in recent timing estimates of recovery from depression. Additionally, in contrast to results obtained under reduced release conditions, augmentation could be driven to a maximal level, occluding paired-pulse facilitation and other mechanisms that increase release efficiency.


Subject(s)
Hippocampus/physiology , Neuronal Plasticity/physiology , Synapses/physiology , Animals , Axonal Transport/physiology , Axons/physiology , Body Temperature/physiology , Calcium/metabolism , Cells, Cultured , Electrophysiology , Fluorescent Dyes , Patch-Clamp Techniques , Rats , Synaptic Transmission/physiology
18.
J Neurosci ; 22(22): 9708-20, 2002 Nov 15.
Article in English | MEDLINE | ID: mdl-12427826

ABSTRACT

Typical fast chemical synapses in the brain weaken transiently during normal high-frequency use after expending their presynaptic supply of release-ready vesicles. Although it takes several seconds for the readily releasable pool (RRP) to refill during periods of rest, it has been suggested that the replenishment process may be orders of magnitude faster when synapses are active. Here, we measure this replenishment rate at active Schaffer collateral terminals by determining the maximum rate of release that can still be elicited when the RRP is almost completely exhausted. On average, we find that spent vesicles are replaced at a maximum unitary rate of 0.24/sec during periods of intense activity. Because the replenishment rate is similar during subsequent periods of rest, we conclude that no special mechanism accelerates the mobilization of neurotransmitter in active terminals beyond the previously reported, several-fold, residual calcium-driven modulation that persists for several seconds after bouts of intense synaptic activity. In the course of this analysis, we provide new evidence supporting the hypothesis that a simple enzymatic step limits the rate at which reserve synaptic vesicles become ready to undergo exocytosis.


Subject(s)
Exocytosis/physiology , Neurons/metabolism , Synaptic Transmission/physiology , Synaptic Vesicles/metabolism , Action Potentials/physiology , Animals , Calcium/metabolism , Electric Stimulation/methods , Hippocampus/cytology , Hippocampus/metabolism , In Vitro Techniques , Kinetics , Mice , Models, Neurological , Neuronal Plasticity/physiology , Neurons/cytology , Patch-Clamp Techniques , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...